IBRXImmunityBio Inc
IBRX
ImmunityBio Inc28,634
Mkt Cap
$7.31BVolume
7.72M52W High
$12.4352W Low
$1.83PE Ratio
-18.24IBRX Fundamentals
Price
$7.11Prev Close
$7.10Open
$7.0550D MA
$8.13Beta
1.86Avg. Volume
13.93MEPS (Annual)
-$0.382P/B
-14.37Rev/Employee
$163,947.90$2,424.07
IBRX Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages IBRX Investors with Losses to Contact the Firm
IBRX Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages IBRX Investors with Losses to Contact the Firm IBRX Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages IBRX Investors...
PR Newswire·3h ago
ImmunityBio Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ImmunityBio, Inc. - IBRX
ImmunityBio Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ImmunityBio, Inc. - IBRX ImmunityBio...
PR Newswire·2d ago
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ImmunityBio, Inc. Of Class Action Lawsuit and Upcoming Deadlines - IBRX
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ImmunityBio, Inc. Of Class Action Lawsuit and Upcoming Deadlines - IBRX INVESTOR ALERT: Pomerantz Law Firm...
PR Newswire·3d ago
INVESTOR REMINDER: Berger Montague Notifies ImmunityBio, Inc. (NASDAQ: IBRX) Investors of a Class Action Lawsuit and Deadline
INVESTOR REMINDER: Berger Montague Notifies ImmunityBio, Inc. (NASDAQ: IBRX) Investors of a Class Action Lawsuit and Deadline INVESTOR REMINDER: Berger Montague Notifies ImmunityBio, Inc. (NASDAQ...
PR Newswire·3d ago
IBRX INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds ImmunityBio (IBRX) Investors of Securities Class Action Deadline on May 26, 2026
IBRX INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds ImmunityBio (IBRX) Investors of Securities Class Action Deadline on May 26, 2026 IBRX INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi...
PR Newswire·3d ago
IBRX Lawsuit Alleges Chairman Allegedly Overstated Drug Capabilities - ImmunityBio Investors Face Losses Following Chairman Allegedly Overstated Drug Capabilities: SueWallSt
IBRX Lawsuit Alleges Chairman Allegedly Overstated Drug Capabilities - ImmunityBio Investors Face Losses Following Chairman Allegedly Overstated Drug Capabilities: SueWallSt IBRX Lawsuit Alleges...
PR Newswire·3d ago
IBRX Lawsuit Alleges Company Allegedly Violated Drug Promotion Laws - ImmunityBio Investors Face Losses Following Company Allegedly Violated Drug Promotion Laws: Hagens Berman
IBRX Lawsuit Alleges Company Allegedly Violated Drug Promotion Laws - ImmunityBio Investors Face Losses Following Company Allegedly Violated Drug Promotion Laws: Hagens Berman IBRX Lawsuit Alleges...
PR Newswire·3d ago
IBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law Firm
IBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law Firm IBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Securities Fraud Lawsuit...
PR Newswire·4d ago
IBRX Investor Alert: ImmunityBio Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Promoted Unapproved Drug Uses: Levi & Korsinsky
IBRX Investor Alert: ImmunityBio Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Promoted Unapproved Drug Uses: Levi & Korsinsky IBRX...
PR Newswire·4d ago
<
1
2
...
>